Los Angeles, CALIFORNIA3 Active Studies

Sarcoma Soft Tissue Clinical Trials in Los Angeles, CALIFORNIA

Find 3 actively recruiting sarcoma soft tissue clinical trials in Los Angeles, CALIFORNIA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
1,477
Enrolling

Recruiting Sarcoma Soft Tissue Studies in Los Angeles

About Sarcoma Soft Tissue Clinical Trials in Los Angeles

Soft tissue sarcomas are rare cancers that develop in the soft tissues of the body including muscle, fat, blood vessels, and tendons. There are more than 50 subtypes, each with different characteristics. Treatment includes surgery, radiation, and chemotherapy, with newer targeted therapies under investigation.

There are currently 3 sarcoma soft tissue clinical trials recruiting participants in Los Angeles, CALIFORNIA. These studies are seeking a combined 1,477 participants. Research is being sponsored by Immunocore Ltd, PharmaMar, Polaris Group. Clinical trial participation is free and participants receive study-related medical care at no cost.

Sarcoma Soft Tissue Clinical Trials in Los Angeles — FAQ

Are there sarcoma soft tissue clinical trials in Los Angeles?

Yes, there are 3 sarcoma soft tissue clinical trials currently recruiting in Los Angeles, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What sarcoma soft tissue treatments are being tested?

The 3 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for sarcoma soft tissue.

Data updated March 2, 2026 from ClinicalTrials.gov